Skip to content
healthcare.dev

Methylphenidate Hydrochloride

NDC 64980-221, Methylphenidate Hydrochloride, tablet, chewable, from Rising Pharma Holdings, Inc..

Product NDC
64980-221
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205756
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-221 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHYLPHENIDATE HYDROCHLORIDE2.5 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
64980-221-0164980022101100 TABLET, CHEWABLE in 1 BOTTLE (64980-221-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e5cb0740-813f-4dce-8c29-d7680c66e77c
  • NADAC price for package 64980022101

    GET /v1/drugs/nadac/64980022101

Use it

Look up 64980-221 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-221 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-221. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.